Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05520099 · ClinicalTrials.gov registry record
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
A clinical trial of Cancer and Colorectal Cancer, sponsored by Elephas.
- Recruiting
- Registry status
- 416
- Enrollment target
- 12
- Study locations
NCT05520099: Recruiting study of Cancer and Colorectal Cancer, sponsored by Elephas.
NCT05520099 is a study of Cancer and Colorectal Cancer that is actively recruiting participants, run by Elephas. The registered enrollment target is 416 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05520099, a study of Cancer and Colorectal Cancer, is actively recruiting participants, sponsored by Elephas.
- RECRUITING
- Registry status
- 416 participants
- Enrollment target
- 12
- Study locations
Study Summary
The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method
Primary Outcome
The ex-vivo prognostic accuracy of the Elephas live tumor diagnostic platform will be determined using in-vivo RECIST 1.1 as the reference method.
Conditions Studied
Interventions
- PROCEDURE Core Needle Biopsy, Forceps Biopsy, Punch Biopsy
Study Locations (12)
Florida
- AdventHealth Orlando - Orlando
- Memorial Health System - Pembroke Pines
- Cleveland Clinic Florida - Stuart
- University of South Florida (Tampa General Hospital) - Tampa
Arkansas
- CARTI Cancer Center - Little Rock
California
- Salinas Valley Memorial Healthcare System - Salinas
Kentucky
- University of Louisville James Graham Brown Cancer Center - Louisville
Maryland
- Meritus Center for Clinical Research - Hagerstown
New Jersey
- John Theurer Cancer Center - Hackensack
New York
- Roswell Park Comprehensive Cancer Center - Buffalo
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2023-06-26 |
| Est. Completion | 2027-01 |
What NCT05520099 shows while recruiting
NCT05520099 is an observational study that tracks outcomes without assigning an intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (88% lower).
The record links to 10 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Core Needle Biopsy, Forceps Biopsy, Punch Biopsy is the first listed.
NCT05520099 lists 12 locations in 9 states (Florida, Arkansas, California).
Frequently Asked Questions
What is clinical trial NCT05520099 about?
NCT05520099 is a clinical study titled "Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform". The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method
What is the current status of trial NCT05520099?
This trial is currently recruiting. The enrollment target is 416 participants. The study started on 2023-06-26. Estimated completion is 2027-01.
What conditions does trial NCT05520099 study?
This clinical trial studies the following conditions: Cancer, Colorectal Cancer, Bladder Cancer, Kidney Cancer, Urothelial Carcinoma Bladder.
What interventions are being tested in trial NCT05520099?
The interventions under investigation include: Core Needle Biopsy, Forceps Biopsy, Punch Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05520099?
This trial is sponsored by Elephas, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05520099 being conducted?
This trial has 12 study locations across Arkansas, California, Florida, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05520099's enrollment target sits among peer trials
416 144th of 615 higher than 472 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
- NCT06111040 · 416 participants · NA
Nurturing Needs Study: Parenting Food Motivated Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI